{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:54:46Z","timestamp":1770015286110,"version":"3.49.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T00:00:00Z","timestamp":1484611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168975","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T13:45:07Z","timestamp":1484660707000},"page":"e0168975","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Systematic Review of Ebola Treatment Trials to Assess the Extent to Which They Adhere to Ethical Guidelines"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-8204","authenticated-orcid":true,"given":"Thomas","family":"Richardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0220-0589","authenticated-orcid":true,"given":"Andrew McDonald","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Draper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation. Geneva: World Health Organisation. Ebola situation report\u201410 June 2016; 2016 Jun 10 [cited 2016 Nov 11]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/208883\/1\/ebolasitrep_10Jun2016_eng.pdf<\/ext-link>."},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMp1409903","article-title":"\u2014new challenges, new global response and responsibility","volume":"371","author":"TR Frieden","year":"2014","journal-title":"N Engl J Med"},{"key":"ref3","unstructured":"Wellcome Trust. London: Wellcome Trust. Ebola research funding initiative; 2014 Nov [cited 2015 Dec 8]. Available from: http:\/\/www.wellcome.ac.uk\/\/Funding\/Biomedical-science\/Funded-projects\/Major-initiatives\/wtp057179.htm<\/ext-link>."},{"key":"ref4","unstructured":"National Center for Emerging and Zoonotic Infectious Diseases Division of High-Consequence Pathogens and Pathology (DHCPP). Ebola virus disease factsheet; 2015 Nov 8 [cited 2015 Dec 8]. Available from: http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-factsheet.pdf<\/ext-link>."},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/B:JOTS.0000048949.43570.6a","article-title":"Ethical issues pertaining to research in the aftermath of disaster","volume":"17","author":"LK Collogan","year":"2004","journal-title":"Journal of Traumatic Stress"},{"issue":"16","key":"ref6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jama.1995.03520400053044","article-title":"Informed consent in emergency research","volume":"273","author":"MH Biros","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/B:JOTS.0000048952.81894.f3","article-title":"The concept of vulnerability in disaster research","volume":"17","author":"C Levine","year":"2004","journal-title":"Journal of Traumatic Stress"},{"key":"ref8","unstructured":"World Health Organisation. Geneva: World Health Organisation. Ethical considerations for use of unregistered interventions for Ebola viral disease report of an advisory panel to WHO; 2014 Aug 11 [cited 2015 Dec 8]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/130997\/1\/WHO_HIS_KER_GHE_14.1_eng.pdf<\/ext-link>."},{"key":"ref9","unstructured":"World Health Organisation. Geneva: World Health Organisation. Public report Ebola R&D landscape of clinical candidates and trials; 2015 Oct [cited 2015 Dec 5]. Available from: http:\/\/www.who.int\/medicines\/ebola-treatment\/EbolaR_D_public-report_oct2015.pdf<\/ext-link>."},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"e00716","DOI":"10.1128\/mBio.00716-15","article-title":"Treating the host response to Ebola virus disease with generic Statins and angiotensin receptor Blockers","volume":"6","author":"DS Fedson","year":"2015","journal-title":"mBio"},{"key":"ref11","unstructured":"Pan African Clinical Trials Registry. Tygerberg, South Africa. Clinical study protocol to assess efficacy and safety of amiodarone in patients with Ebola Virus Disease (EVD) in Sierra Leone.; 2015 Jan 26 [cited 2015 Dec 5]. Available from: http:\/\/www.pactr.org\/ATMWeb\/appmanager\/atm\/atmregistry?_nfpb=true&_windowLabel=BasicSearchUpdateController_1&BasicSearchUpdateController_1_actionOverride=%2Fpageflows%2Ftrial%2FbasicSearchUpdate%2FviewTrail&BasicSearchUpdateController_1id=1014<\/ext-link>"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1136\/bmj.g7198","article-title":"Doctors trial amiodarone for Ebola in Sierra Leone","volume":"349","author":"F Turone","year":"2014","journal-title":"BMJ"},{"key":"ref13","article-title":"Doctors trial amiodarone for Ebola in Sierra Leone: Rapid Responses","author":"A Gupta-Wright","year":"2014","journal-title":"BMJ"},{"key":"ref14","article-title":"Standards and operational guidance for ethics review of health-related research with human participants","year":"2011"},{"key":"ref15","article-title":"M\u00e9decins Sans Fronti\u00e8res\u2014Research Ethics Framework Guidance document","year":"2013"},{"issue":"20","key":"ref16","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","article-title":"What makes clinical research ethical?","volume":"283","author":"EJ Emanuel","year":"2000","journal-title":"JAMA"},{"key":"ref17","unstructured":"Curry DR, Waldman RJ, Caplan AL. An Ethical Framework for the development and review of health research proposals involving humanitarian contexts: Project Final Report. Cardiff: Research for Health in Humanitarian Crises (R2HC) Programme of the Enhancing Learning and Research for Humanitarian Assistance (ELRHA); 2014 Jan [cited 2016 Nov 15]. Available from: http:\/\/www.elrha.org\/wp-content\/uploads\/2015\/01\/FINAL-R2HC-Ethical-Framework_Final-Report_24-January-2014_0.pdf<\/ext-link>."},{"key":"ref18","article-title":"Origins of the 2014 Ebola epidemic","year":"2015"},{"key":"ref19","unstructured":"Ovid MEDLINE(R) 1946 to February Week 3 2016. Wolters Kluwer. Ovid: Welcome to Ovid [cited 2016 Feb 28]. Available from: http:\/\/ovidsp.tx.ovid.com\/sp-3.17.0a\/ovidweb.cgi<\/ext-link>."},{"key":"ref20","unstructured":"Embase: Excerpta Medica Database Guide. 2016 Reed Elsevier Properties SA [cited 2015 Mar 30]. Available from: https:\/\/www.embase.com\/login<\/ext-link>."},{"key":"ref21","unstructured":"Cochrane Library. John Wiley & Sons, Inc. [cited 2015 Dec 8]. Available from: http:\/\/onlinelibrary.wiley.com\/cochranelibrary\/search\/<\/ext-link>."},{"key":"ref22","article-title":"PROSPERO\u2014international prospective register of systematic reviews"},{"key":"ref23","article-title":"International Clinical Trials Registry Platform: search portal","year":"2014"},{"key":"ref24","unstructured":"United States of America National Institutes of Health. ClinicalTrials.gov. Advanced search [cited 2015 Dec 8]. Available from: https:\/\/clinicaltrials.gov\/ct2\/search\/advanced<\/ext-link>."},{"key":"ref25","unstructured":"Pan African Clinical Trials Registry South African Cochrane Centre. Pan African Clinical Trials Registry [cited 2015 Dec 2]. Available from: http:\/\/www.pactr.org\/<\/ext-link>."},{"key":"ref26","unstructured":"Mary I, Bobay V, Renaud J, Mermin E, Salvetti, Vittoria M, et al. Search OpenGrey; 1988 [cited 2015 Dec 4]. Available from: http:\/\/www.opengrey.eu\/search\/<\/ext-link>."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"JPT Higgins","year":"2011","journal-title":"BMJ. BMJ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of Convalescent plasma for Ebola virus disease in guinea","volume":"374","author":"J van Griensven","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with Favipiravir for Ebola virus disease (the JIKI trial): A historically controlled, single-arm proof-of-concept trial in guinea","volume":"13","author":"D Sissoko","year":"2016","journal-title":"PLOS Medicine"},{"key":"ref30","article-title":"Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola) (EASE)","year":"2014"},{"key":"ref31","article-title":"Multiple Treatments for Ebola Virus Disease (EVD)","year":"2015"},{"key":"ref32","article-title":"Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection","year":"2015"},{"key":"ref33","article-title":"Efficacy of Favipiravir Against Severe Ebola Virus Disease","year":"2016"},{"key":"ref34","article-title":"Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment (EVD001)","year":"2015"},{"key":"ref35","article-title":"A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease","year":"2014"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"e00716","DOI":"10.1128\/mBio.00716-15","article-title":"Treating the host response to Ebola virus disease with generic Statins and angiotensin receptor Blockers","volume":"6","author":"DS Fedson","year":"2015","journal-title":"mBio"},{"key":"ref37","article-title":"Efficacy of Favipiravir (T-705) in patients infected with Ebola virus in Sierra Leone: a preliminary clinical trial","year":"2015"},{"key":"ref38","article-title":"Convalescent plasma for early Ebola virus disease in Sierra Leone","author":"V Winters","year":"2015"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e1001997","DOI":"10.1371\/journal.pmed.1001997","article-title":"Experimental treatment of Ebola virus disease with TKM-130803: A single-arm phase 2 clinical trial","volume":"13","author":"J Dunning","year":"2016","journal-title":"PLOS Medicine"},{"key":"ref40","article-title":"Treatment of Ebola virus disease with Traditional Chinese Medicine (TCM): A prospective clinical study","year":"2014"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e0162199","DOI":"10.1371\/journal.pone.0162199","article-title":"Experimental treatment of Ebola virus disease with Brincidofovir","volume":"11","author":"J Dunning","year":"2016","journal-title":"PLOS ONE"},{"key":"ref42","article-title":"Investigation on the efficacy and safety of favipiravir in patients who are infected or strongly suspected of being infected with Ebola virus","year":"2015"},{"key":"ref43","article-title":"A Pilot Study to Evaluate the Safety and Efficacy of IFN-\u00df (AVONEX\u00ae) in the Treatment of Patients Presenting with Ebola Virus Illness","author":"E Fish","year":"2015"},{"issue":"20","key":"ref44","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"ref45","article-title":"Defining research","year":"2013"},{"key":"ref46","article-title":"International ethical guidelines for biomedical research involving human subjects","year":"2002"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2015.12.005","article-title":"Progression of Ebola Therapeutics during the 2014\u20132015 outbreak","volume":"22","author":"EJ Mendoza","year":"2016","journal-title":"Trends in Molecular Medicine"},{"key":"ref48","article-title":"Compassionate use of experimental treatments for Ebola virus disease: Outcomes in 14 patients admitted from august to November, 2014","year":"2015"},{"key":"ref49","unstructured":"World Health Organization. Ethical issues relating to study design for trials on therapeutics for Ebola Virus Disease. WHO Ethics Working Group Meeting. 20\u201321 October. Summary of Discussion. Geneva: World Health Organisation; 2014 Oct."},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7326\/M14-2002","article-title":"Drug and vaccine access in the Ebola epidemic: Advising caution in compassionate use","volume":"162","author":"A Hantel","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"9957","key":"ref51","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(14)61315-5","article-title":"Ethical considerations of experimental interventions in the Ebola outbreak","volume":"384","author":"A Rid","year":"2014","journal-title":"The Lancet"},{"key":"ref52","article-title":"What is the ICMJE definition of a clinical trial?","year":"2007"},{"key":"ref53","unstructured":"U.S. Department of Health & Human Services. Washington DC: HHS.gov<\/ext-link>. Code of Federal Regulations. Title 45. Public Welfare. Department for Health and Human Subjects (HHS). Part 46- Protection of Human Subjects. Subpart A. Basic HHS Policy for Protection of Human Research Subjects. Section 46.102; 2016 Feb 16 [cited 2016 Apr 25]. Available from: http:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/regulations\/45-cfr-46\/index.html<\/ext-link>."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S1473-3099(15)00375-8","article-title":"Ebola: Europe\u2013Africa research collaborations","volume":"15","author":"PW Horby","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S1473-3099(15)00344-8","article-title":"Drug assessment in the Ebola virus disease epidemic in west Africa","volume":"15","author":"Y Yazdanpanah","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"issue":"9955","key":"ref56","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0140-6736(14)61735-9","article-title":"Randomisation is essential in Ebola drug trials","volume":"384","author":"D Shaw","year":"2014","journal-title":"The Lancet"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1473-3099(16)00132-8","article-title":"Non-randomised Ebola trials\u2014lessons for optimal outbreak research","volume":"16","author":"G Ippolito","year":"2016","journal-title":"The Lancet Infectious Diseases"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1473-3099(15)70106-4","article-title":"Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?","volume":"15","author":"S Lanini","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e1001815","DOI":"10.1371\/journal.pmed.1001815","article-title":"Evaluating clinical trial designs for investigational treatments of Ebola virus disease","volume":"12","author":"BS Cooper","year":"2015","journal-title":"PLOS Medicine"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1752-1505-3-7","article-title":"Ethics of conducting research in conflict settings","volume":"3","author":"N Ford","year":"2009","journal-title":"Conflict and Health"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1207\/s15327019eb1401_3","article-title":"Regulatory and ethical principles in research involving children and individuals with developmental disabilities","volume":"14","author":"EG Yan","year":"2004","journal-title":"Ethics & Behavior"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.whi.2012.10.003","article-title":"Enrolling pregnant women: Issues in clinical research","volume":"23","author":"MC Blehar","year":"2013","journal-title":"Women\u2019s Health Issues"},{"key":"ref63","article-title":"WHO Trial Registration Data Set (Version 1.2.1)","year":"2014"},{"issue":"16","key":"ref64","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","article-title":"Ebola virus disease in west Africa\u2014the First 9 months of the epidemic and forward projections","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"issue":"9951","key":"ref65","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S0140-6736(14)61345-3","article-title":"Ebola: Towards an international health systems fund","volume":"384","author":"LO Gostin","year":"2014","journal-title":"The Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T13:22:13Z","timestamp":1568726533000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168975"}},"subtitle":[],"editor":[{"given":"Bridget","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168975","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,17]]}}}